Daniel Lesueur serves as Executive at Health Catalyst, Inc., where they oversee executive responsibilities. Since joining the company, Daniel Lesueur has executed 9 insider transactions totaling $206.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 2, 2025 involved selling 3,663 shares valued at $12.3K.
Daniel Lesueur currently holds 198,367 shares of Health Catalyst, Inc. (HCAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Lesueur has been a net seller of HCAT stock. They have purchased $0 and sold $206.1K worth of shares.
Daniel Lesueur's most recent insider trade was on Sep 2, 2025, when they sold 3,663 shares at $3.36 per share.
Get notified when new Form 4 filings are submitted
| $7.58 |
| Discretionary |
| Sep 3, 2024 | HCAT | $12.8K | Payment | 1,761 | $7.27 | Discretionary |
| Aug 5, 2024 | HCAT | $32.2K | Sale | 5,209 | $6.19 | Planned |
| Jul 3, 2024 | HCAT | $32.0K | Sale | 5,208 | $6.15 | Planned |
| Jun 6, 2024 | HCAT | $80.1K | Sale | 11,923 | $6.72 | Planned |
| Jun 3, 2024 | HCAT | $12.2K | Payment | 1,873 | $6.53 | Discretionary |
| Mar 1, 2024 | HCAT | $0 | Award | 70,000 | $N/A | Discretionary |
| Mar 1, 2024 | HCAT | $26.4K | Payment | 3,279 | $8.05 | Discretionary |